Founder of Biogen, Inc., Alnylam Pharmaceuticals, Inc. and PPD Dermatology LLC, Phillip A. Sharp is an entrepreneur is on the board of Alnylam Pharmaceuticals, Inc., Whitehead Institute for Biomedical Research, The Broad Institute, Inc. and Vir Biotechnology, Inc. and Professor at Massachusetts Institute of Technology, Member of The Royal Society, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of American Philosophical Society and Professor at David H. Koch Institute for Integrative Cancer Research.

In his past career Phillip A. Sharp occupied the position of Director & Strategic Advisor at Longwood Fund Management LLC, Director at Biogen, Inc. and Director at PPD Dermatology LLC.

He received a doctorate from the University of Illinois and an undergraduate degree from Union College (Kentucky).